Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:15 pm
| PEG Ratio | -15.85 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Emami Ltd, a prominent player in the personal care industry, reported a market capitalization of ₹22,942 Cr and a share price of ₹526. The company exhibited a steady growth trajectory, with total sales increasing from ₹3,192 Cr in FY 2022 to ₹3,406 Cr in FY 2023. This upward trend is expected to continue as revenues are projected to reach ₹3,809 Cr in FY 2025, reflecting a compound annual growth rate (CAGR) of approximately 9.7% over the three years. Quarterly sales figures also underscore this growth, with the most recent quarter (Dec 2024) recording sales of ₹1,049 Cr, up from ₹836 Cr in Mar 2023. The company has managed to sustain its sales momentum, with a notable rise in operating profit margins, which stood at 28.69% in FY 2025, indicating a strong operational performance compared to sector averages. This growth is supported by robust demand in the personal care segment, aligning with broader industry trends highlighting consumer preference for branded products.
Profitability and Efficiency Metrics
Emami Ltd’s profitability metrics reflect a strong operational framework. The company’s net profit for FY 2023 was ₹627 Cr, with an increase to ₹803 Cr projected for FY 2025, resulting in an impressive net profit margin of 21.38% in FY 2025. The operating profit margin (OPM) reported for the same period stood at 27%, which is commendable compared to typical sector margins. Additionally, the return on equity (ROE) was recorded at 30.2%, showcasing effective utilization of shareholder funds, while return on capital employed (ROCE) remained robust at 32.4%. These metrics are indicative of the company’s operational efficiency and strong market positioning. The interest coverage ratio, reported at 117.09x, further emphasizes Emami’s ability to meet its interest obligations, reflecting low financial risk. However, the cash conversion cycle of 4 days is relatively low, suggesting efficient working capital management, which is a significant advantage in the competitive personal care sector.
Balance Sheet Strength and Financial Ratios
Emami Ltd’s balance sheet demonstrates considerable financial strength, with total assets reported at ₹3,525 Cr for FY 2025. The company has maintained a conservative borrowing strategy, with total borrowings standing at only ₹72 Cr, resulting in a debt-to-equity ratio of 0.02, indicating minimal leverage. The reserves have also shown a healthy increase, reaching ₹2,887 Cr by Sep 2025, which supports the company’s growth initiatives and capital expenditures. The book value per share has risen to ₹61.74, reflecting the company’s solid foundation. Financial ratios such as the current ratio (2.22) and quick ratio (1.83) suggest strong liquidity positions, allowing Emami to comfortably meet its short-term obligations. Moreover, the price-to-book value ratio at 6.85x indicates that the stock is valued at a premium, which can be justified by the company’s strong fundamentals and growth prospects.
Shareholding Pattern and Investor Confidence
Emami Ltd’s shareholding structure reveals a stable and confident investor base. Promoters hold 54.84% of the equity, ensuring continued control and strategic direction. The presence of institutional investors is also noteworthy, with Foreign Institutional Investors (FIIs) accounting for 10.93% and Domestic Institutional Investors (DIIs) holding 25%. This diverse ownership structure is indicative of strong institutional confidence in Emami’s business model and growth trajectory. Over the past few quarters, the percentage of DIIs has increased, reflecting a growing interest among domestic investors. However, the reduction in FII holdings from a peak of 14.02% in Jun 2024 to 10.93% in Sep 2025 may raise some concerns about external investor sentiment. The number of shareholders has increased to 1,26,776, demonstrating sustained retail interest in the stock, which is a positive sign for long-term stability.
Outlook, Risks, and Final Insight
Looking ahead, Emami Ltd is well-positioned to leverage its strong market presence and operational efficiency to drive future growth. The company’s focus on product innovation and expanding distribution channels will likely enhance its competitive edge in the personal care sector. However, potential risks include fluctuations in raw material costs and changing consumer preferences, which could impact profitability. Additionally, increasing competition from both domestic and international brands poses a challenge to maintaining market share. In a scenario where Emami successfully navigates these challenges while capitalizing on growth opportunities, it could see enhanced revenue and profit margins. Conversely, failure to adapt to market dynamics may hinder its growth trajectory. Overall, Emami Ltd’s solid financials and strategic initiatives provide a promising outlook, albeit with caution regarding external market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,520 Cr. | 293 | 334/190 | 76.5 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 42.4 Cr. | 25.5 | 37.0/23.3 | 83.2 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 115 Cr. | 120 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 608 Cr. | 403 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 10,436 Cr. | 284 | 423/268 | 28.5 | 55.8 | 1.23 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 70,621.43 Cr | 1,916.12 | 59.48 | 112.70 | 0.75% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 814 | 983 | 836 | 826 | 865 | 996 | 891 | 906 | 891 | 1,049 | 963 | 904 | 799 |
| Expenses | 621 | 689 | 636 | 636 | 632 | 682 | 682 | 692 | 645 | 715 | 744 | 692 | 622 |
| Operating Profit | 193 | 294 | 199 | 190 | 233 | 314 | 209 | 214 | 246 | 334 | 219 | 212 | 177 |
| OPM % | 24% | 30% | 24% | 23% | 27% | 32% | 24% | 24% | 28% | 32% | 23% | 23% | 22% |
| Other Income | 42 | 7 | 14 | 8 | 11 | 11 | 11 | 10 | 22 | 15 | 21 | 22 | 21 |
| Interest | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 |
| Depreciation | 48 | 47 | 64 | 46 | 46 | 46 | 48 | 44 | 45 | 46 | 44 | 44 | 45 |
| Profit before tax | 186 | 251 | 148 | 150 | 196 | 276 | 169 | 178 | 220 | 301 | 194 | 187 | 150 |
| Tax % | 3% | 7% | 4% | 9% | 8% | 6% | 13% | 16% | 4% | 7% | 16% | 12% | 1% |
| Net Profit | 180 | 233 | 142 | 137 | 180 | 261 | 147 | 151 | 211 | 279 | 162 | 164 | 148 |
| EPS in Rs | 4.17 | 5.38 | 3.27 | 3.14 | 4.09 | 5.92 | 3.41 | 3.50 | 4.87 | 6.39 | 3.72 | 3.76 | 3.40 |
Last Updated: January 1, 2026, 9:04 pm
Below is a detailed analysis of the quarterly data for Emami Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 799.00 Cr.. The value appears to be declining and may need further review. It has decreased from 904.00 Cr. (Jun 2025) to 799.00 Cr., marking a decrease of 105.00 Cr..
- For Expenses, as of Sep 2025, the value is 622.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 692.00 Cr. (Jun 2025) to 622.00 Cr., marking a decrease of 70.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 177.00 Cr.. The value appears to be declining and may need further review. It has decreased from 212.00 Cr. (Jun 2025) to 177.00 Cr., marking a decrease of 35.00 Cr..
- For OPM %, as of Sep 2025, the value is 22.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Jun 2025) to 22.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Jun 2025) to 21.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Jun 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 45.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 44.00 Cr. (Jun 2025) to 45.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 150.00 Cr.. The value appears to be declining and may need further review. It has decreased from 187.00 Cr. (Jun 2025) to 150.00 Cr., marking a decrease of 37.00 Cr..
- For Tax %, as of Sep 2025, the value is 1.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Jun 2025) to 1.00%, marking a decrease of 11.00%.
- For Net Profit, as of Sep 2025, the value is 148.00 Cr.. The value appears to be declining and may need further review. It has decreased from 164.00 Cr. (Jun 2025) to 148.00 Cr., marking a decrease of 16.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.40. The value appears to be declining and may need further review. It has decreased from 3.76 (Jun 2025) to 3.40, marking a decrease of 0.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:25 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,700 | 2,076 | 2,358 | 2,488 | 2,531 | 2,695 | 2,655 | 2,881 | 3,192 | 3,406 | 3,578 | 3,809 | 3,715 |
| Expenses | 1,255 | 1,536 | 1,670 | 1,729 | 1,812 | 1,970 | 1,970 | 2,000 | 2,254 | 2,550 | 2,632 | 2,796 | 2,773 |
| Operating Profit | 445 | 541 | 688 | 759 | 719 | 725 | 685 | 880 | 938 | 855 | 946 | 1,014 | 942 |
| OPM % | 26% | 26% | 29% | 31% | 28% | 27% | 26% | 31% | 29% | 25% | 26% | 27% | 25% |
| Other Income | 53 | 91 | 44 | 31 | 19 | 25 | 46 | 69 | 90 | 69 | 41 | 68 | 79 |
| Interest | 5 | 5 | 54 | 58 | 34 | 21 | 21 | 13 | 5 | 7 | 10 | 9 | 10 |
| Depreciation | 35 | 34 | 255 | 309 | 311 | 325 | 336 | 367 | 335 | 247 | 186 | 178 | 179 |
| Profit before tax | 457 | 592 | 423 | 424 | 393 | 403 | 374 | 569 | 688 | 670 | 791 | 894 | 832 |
| Tax % | 12% | 18% | 14% | 20% | 22% | 25% | 19% | 20% | -22% | 6% | 8% | 10% | |
| Net Profit | 402 | 485 | 363 | 340 | 306 | 303 | 302 | 455 | 837 | 627 | 724 | 803 | 754 |
| EPS in Rs | 8.87 | 10.70 | 8.00 | 7.50 | 6.77 | 6.68 | 6.67 | 10.23 | 19.02 | 14.50 | 16.58 | 18.48 | 17.27 |
| Dividend Payout % | 39% | 33% | 44% | 47% | 52% | 60% | 60% | 78% | 42% | 55% | 48% | 54% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 20.65% | -25.15% | -6.34% | -10.00% | -0.98% | -0.33% | 50.66% | 83.96% | -25.09% | 15.47% | 10.91% |
| Change in YoY Net Profit Growth (%) | 0.00% | -45.80% | 18.82% | -3.66% | 9.02% | 0.65% | 50.99% | 33.29% | -109.05% | 40.56% | -4.56% |
Emami Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 21% |
| 3 Years: | -1% |
| TTM: | 10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 31% |
| 3 Years: | 30% |
| Last Year: | 30% |
Last Updated: September 5, 2025, 3:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:12 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 45 | 45 | 44 | 44 | 44 | 44 | 44 | 44 |
| Reserves | 909 | 1,208 | 1,589 | 1,732 | 1,991 | 2,031 | 1,778 | 1,718 | 2,032 | 2,259 | 2,403 | 2,651 | 2,887 |
| Borrowings | 38 | 36 | 671 | 473 | 326 | 110 | 210 | 101 | 282 | 91 | 94 | 90 | 72 |
| Other Liabilities | 333 | 410 | 409 | 376 | 458 | 633 | 644 | 656 | 692 | 703 | 728 | 741 | 668 |
| Total Liabilities | 1,302 | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,525 | 3,671 |
| Fixed Assets | 396 | 453 | 1,918 | 1,994 | 1,802 | 1,680 | 1,459 | 1,132 | 1,344 | 1,245 | 1,114 | 984 | 917 |
| CWIP | 12 | 29 | 67 | 22 | 30 | 36 | 8 | 6 | 3 | 6 | 8 | 15 | 18 |
| Investments | 296 | 501 | 104 | 128 | 314 | 187 | 156 | 255 | 303 | 293 | 442 | 676 | 858 |
| Other Assets | 599 | 693 | 604 | 460 | 652 | 915 | 1,055 | 1,126 | 1,400 | 1,551 | 1,706 | 1,850 | 1,878 |
| Total Assets | 1,302 | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,525 | 3,671 |
Below is a detailed analysis of the balance sheet data for Emami Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 44.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,887.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,651.00 Cr. (Mar 2025) to 2,887.00 Cr., marking an increase of 236.00 Cr..
- For Borrowings, as of Sep 2025, the value is 72.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 90.00 Cr. (Mar 2025) to 72.00 Cr., marking a decrease of 18.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 668.00 Cr.. The value appears to be improving (decreasing). It has decreased from 741.00 Cr. (Mar 2025) to 668.00 Cr., marking a decrease of 73.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,671.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,525.00 Cr. (Mar 2025) to 3,671.00 Cr., marking an increase of 146.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 917.00 Cr.. The value appears to be declining and may need further review. It has decreased from 984.00 Cr. (Mar 2025) to 917.00 Cr., marking a decrease of 67.00 Cr..
- For CWIP, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 858.00 Cr.. The value appears strong and on an upward trend. It has increased from 676.00 Cr. (Mar 2025) to 858.00 Cr., marking an increase of 182.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,878.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,850.00 Cr. (Mar 2025) to 1,878.00 Cr., marking an increase of 28.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,671.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,525.00 Cr. (Mar 2025) to 3,671.00 Cr., marking an increase of 146.00 Cr..
Notably, the Reserves (2,887.00 Cr.) exceed the Borrowings (72.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 407.00 | 505.00 | 17.00 | 286.00 | 393.00 | 615.00 | 475.00 | 779.00 | 656.00 | 764.00 | 852.00 | -89.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 18 | 20 | 14 | 22 | 29 | 42 | 29 | 37 | 44 | 50 | 43 |
| Inventory Days | 76 | 59 | 68 | 83 | 87 | 88 | 102 | 118 | 121 | 100 | 102 | 94 |
| Days Payable | 77 | 90 | 112 | 85 | 109 | 115 | 135 | 138 | 138 | 124 | 143 | 133 |
| Cash Conversion Cycle | 16 | -13 | -24 | 12 | 1 | 2 | 9 | 10 | 19 | 20 | 9 | 4 |
| Working Capital Days | -7 | -16 | -54 | -62 | -32 | -6 | 7 | -3 | 0 | 28 | 30 | 25 |
| ROCE % | 50% | 61% | 30% | 23% | 22% | 19% | 18% | 29% | 31% | 28% | 32% | 32% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 12,874,798 | 1 | 683.01 | 12,274,798 | 2025-12-15 01:38:08 | 4.89% |
| Kotak Midcap Fund | 9,156,279 | 0.8 | 485.74 | 11,495,225 | 2025-12-15 01:38:08 | -20.35% |
| HDFC Mid Cap Fund | 7,419,485 | 0.43 | 393.6 | N/A | N/A | N/A |
| SBI Large & Midcap Fund | 6,500,000 | 0.93 | 344.83 | 6,500,000 | 2025-04-22 15:56:58 | 0% |
| Nippon India Multi Cap Fund | 6,221,481 | 0.66 | 330.05 | 5,721,481 | 2025-12-15 01:38:08 | 8.74% |
| DSP Aggressive Hybrid Fund | 4,679,374 | 2.05 | 248.24 | N/A | N/A | N/A |
| DSP ELSS Tax Saver Fund | 4,345,045 | 1.31 | 230.5 | 4,224,369 | 2025-12-07 16:58:21 | 2.86% |
| DSP Mid Cap Fund | 4,058,472 | 1.08 | 215.3 | 5,265,742 | 2025-12-07 16:58:21 | -22.93% |
| Aditya Birla Sun Life Large Cap Fund | 3,979,053 | 0.67 | 211.09 | 3,753,696 | 2025-12-15 01:38:08 | 6% |
| DSP Large & Mid Cap Fund | 3,434,700 | 1.06 | 182.21 | 3,406,365 | 2025-12-15 01:38:08 | 0.83% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 18.48 | 16.55 | 14.50 | 18.88 | 10.23 |
| Diluted EPS (Rs.) | 18.48 | 16.55 | 14.50 | 18.88 | 10.23 |
| Cash EPS (Rs.) | 22.74 | 20.93 | 20.00 | 26.88 | 18.58 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 61.74 | 56.30 | 52.43 | 47.02 | 39.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 61.74 | 56.30 | 52.43 | 47.02 | 39.63 |
| Revenue From Operations / Share (Rs.) | 87.27 | 81.97 | 77.20 | 72.36 | 64.80 |
| PBDIT / Share (Rs.) | 25.05 | 22.83 | 21.12 | 23.75 | 21.45 |
| PBIT / Share (Rs.) | 20.96 | 18.57 | 15.51 | 16.16 | 13.19 |
| PBT / Share (Rs.) | 20.75 | 18.20 | 15.35 | 15.93 | 12.89 |
| Net Profit / Share (Rs.) | 18.66 | 16.67 | 14.39 | 19.30 | 10.32 |
| NP After MI And SOA / Share (Rs.) | 18.48 | 16.58 | 14.50 | 19.02 | 10.23 |
| PBDIT Margin (%) | 28.69 | 27.84 | 27.35 | 32.81 | 33.09 |
| PBIT Margin (%) | 24.02 | 22.64 | 20.09 | 22.33 | 20.35 |
| PBT Margin (%) | 23.77 | 22.20 | 19.87 | 22.01 | 19.89 |
| Net Profit Margin (%) | 21.38 | 20.34 | 18.64 | 26.66 | 15.93 |
| NP After MI And SOA Margin (%) | 21.17 | 20.22 | 18.77 | 26.28 | 15.78 |
| Return on Networth / Equity (%) | 29.92 | 29.57 | 27.77 | 40.40 | 25.79 |
| Return on Capital Employeed (%) | 33.22 | 32.14 | 28.68 | 33.28 | 32.22 |
| Return On Assets (%) | 22.82 | 22.06 | 20.56 | 27.44 | 18.04 |
| Total Debt / Equity (X) | 0.02 | 0.02 | 0.03 | 0.12 | 0.05 |
| Asset Turnover Ratio (%) | 1.12 | 1.12 | 1.00 | 1.07 | 1.04 |
| Current Ratio (X) | 2.22 | 1.87 | 1.78 | 1.17 | 1.61 |
| Quick Ratio (X) | 1.83 | 1.44 | 1.32 | 0.78 | 1.18 |
| Inventory Turnover Ratio (X) | 12.06 | 2.36 | 2.43 | 2.72 | 2.65 |
| Dividend Payout Ratio (NP) (%) | 43.29 | 48.26 | 55.18 | 42.38 | 78.20 |
| Dividend Payout Ratio (CP) (%) | 35.46 | 38.39 | 39.79 | 30.29 | 43.27 |
| Earning Retention Ratio (%) | 56.71 | 51.74 | 44.82 | 57.62 | 21.80 |
| Cash Earning Retention Ratio (%) | 64.54 | 61.61 | 60.21 | 69.71 | 56.73 |
| Interest Coverage Ratio (X) | 117.09 | 99.86 | 126.05 | 206.51 | 71.83 |
| Interest Coverage Ratio (Post Tax) (X) | 88.24 | 74.54 | 86.90 | 169.83 | 35.58 |
| Enterprise Value (Cr.) | 18251.70 | 18339.38 | 0.00 | 19900.10 | 21407.37 |
| EV / Net Operating Revenue (X) | 4.79 | 5.13 | 0.00 | 6.23 | 7.43 |
| EV / EBITDA (X) | 16.70 | 18.41 | 0.00 | 19.00 | 22.46 |
| MarketCap / Net Operating Revenue (X) | 4.85 | 5.16 | 0.00 | 6.19 | 7.53 |
| Retention Ratios (%) | 56.70 | 51.73 | 44.81 | 57.61 | 21.79 |
| Price / BV (X) | 6.85 | 7.55 | 0.00 | 9.51 | 12.30 |
| Price / Net Operating Revenue (X) | 4.85 | 5.16 | 0.00 | 6.19 | 7.53 |
| EarningsYield | 0.04 | 0.03 | 0.00 | 0.04 | 0.02 |
After reviewing the key financial ratios for Emami Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 16.55 (Mar 24) to 18.48, marking an increase of 1.93.
- For Diluted EPS (Rs.), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 16.55 (Mar 24) to 18.48, marking an increase of 1.93.
- For Cash EPS (Rs.), as of Mar 25, the value is 22.74. This value is within the healthy range. It has increased from 20.93 (Mar 24) to 22.74, marking an increase of 1.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.74. It has increased from 56.30 (Mar 24) to 61.74, marking an increase of 5.44.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.74. It has increased from 56.30 (Mar 24) to 61.74, marking an increase of 5.44.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 87.27. It has increased from 81.97 (Mar 24) to 87.27, marking an increase of 5.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 25.05. This value is within the healthy range. It has increased from 22.83 (Mar 24) to 25.05, marking an increase of 2.22.
- For PBIT / Share (Rs.), as of Mar 25, the value is 20.96. This value is within the healthy range. It has increased from 18.57 (Mar 24) to 20.96, marking an increase of 2.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 20.75. This value is within the healthy range. It has increased from 18.20 (Mar 24) to 20.75, marking an increase of 2.55.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 18.66. This value is within the healthy range. It has increased from 16.67 (Mar 24) to 18.66, marking an increase of 1.99.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 16.58 (Mar 24) to 18.48, marking an increase of 1.90.
- For PBDIT Margin (%), as of Mar 25, the value is 28.69. This value is within the healthy range. It has increased from 27.84 (Mar 24) to 28.69, marking an increase of 0.85.
- For PBIT Margin (%), as of Mar 25, the value is 24.02. This value exceeds the healthy maximum of 20. It has increased from 22.64 (Mar 24) to 24.02, marking an increase of 1.38.
- For PBT Margin (%), as of Mar 25, the value is 23.77. This value is within the healthy range. It has increased from 22.20 (Mar 24) to 23.77, marking an increase of 1.57.
- For Net Profit Margin (%), as of Mar 25, the value is 21.38. This value exceeds the healthy maximum of 10. It has increased from 20.34 (Mar 24) to 21.38, marking an increase of 1.04.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 21.17. This value exceeds the healthy maximum of 20. It has increased from 20.22 (Mar 24) to 21.17, marking an increase of 0.95.
- For Return on Networth / Equity (%), as of Mar 25, the value is 29.92. This value is within the healthy range. It has increased from 29.57 (Mar 24) to 29.92, marking an increase of 0.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 33.22. This value is within the healthy range. It has increased from 32.14 (Mar 24) to 33.22, marking an increase of 1.08.
- For Return On Assets (%), as of Mar 25, the value is 22.82. This value is within the healthy range. It has increased from 22.06 (Mar 24) to 22.82, marking an increase of 0.76.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.12. There is no change compared to the previous period (Mar 24) which recorded 1.12.
- For Current Ratio (X), as of Mar 25, the value is 2.22. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 2.22, marking an increase of 0.35.
- For Quick Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 1.83, marking an increase of 0.39.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.06. This value exceeds the healthy maximum of 8. It has increased from 2.36 (Mar 24) to 12.06, marking an increase of 9.70.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 43.29. This value is within the healthy range. It has decreased from 48.26 (Mar 24) to 43.29, marking a decrease of 4.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 35.46. This value is within the healthy range. It has decreased from 38.39 (Mar 24) to 35.46, marking a decrease of 2.93.
- For Earning Retention Ratio (%), as of Mar 25, the value is 56.71. This value is within the healthy range. It has increased from 51.74 (Mar 24) to 56.71, marking an increase of 4.97.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 64.54. This value is within the healthy range. It has increased from 61.61 (Mar 24) to 64.54, marking an increase of 2.93.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 117.09. This value is within the healthy range. It has increased from 99.86 (Mar 24) to 117.09, marking an increase of 17.23.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 88.24. This value is within the healthy range. It has increased from 74.54 (Mar 24) to 88.24, marking an increase of 13.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 18,251.70. It has decreased from 18,339.38 (Mar 24) to 18,251.70, marking a decrease of 87.68.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has decreased from 5.13 (Mar 24) to 4.79, marking a decrease of 0.34.
- For EV / EBITDA (X), as of Mar 25, the value is 16.70. This value exceeds the healthy maximum of 15. It has decreased from 18.41 (Mar 24) to 16.70, marking a decrease of 1.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.85. This value exceeds the healthy maximum of 3. It has decreased from 5.16 (Mar 24) to 4.85, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 25, the value is 56.70. This value is within the healthy range. It has increased from 51.73 (Mar 24) to 56.70, marking an increase of 4.97.
- For Price / BV (X), as of Mar 25, the value is 6.85. This value exceeds the healthy maximum of 3. It has decreased from 7.55 (Mar 24) to 6.85, marking a decrease of 0.70.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.85. This value exceeds the healthy maximum of 3. It has decreased from 5.16 (Mar 24) to 4.85, marking a decrease of 0.31.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emami Ltd:
- Net Profit Margin: 21.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 33.22% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 29.92% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 88.24
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.83
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.3 (Industry average Stock P/E: 59.48)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 21.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Emami Tower, 687, Anandapur, Kolkata West Bengal 700107 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R S Agarwal | Chairman Emeritus |
| Mr. R S Goenka | Non Executive Chairman |
| Mr. Harsha V Agarwal | Vice Chairman & Mng.Director |
| Mr. Mohan Goenka | Vice Chairman & Whole Time Dir |
| Mr. Sushil K Goenka | Whole Time Director |
| Mrs. Priti A Sureka | Whole Time Director |
| Mr. Prashant Goenka | Whole Time Director |
| Mr. Aditya V Agarwal | Non Executive Director |
| Mr. C K Dhanuka | Independent Director |
| Ms. Mamta Binani | Independent Director |
| Mr. Rajiv Khaitan | Independent Director |
| Ms. Avani V Davda | Independent Director |
| Mr. Anjanmoy Chatterjee | Independent Director |
| Mr. Anjani Kumar Agrawal | Independent Director |
| Mr. Debabrata Sarkar | Independent Director |
| Mr. Anand Rathi | Independent Director |
FAQ
What is the intrinsic value of Emami Ltd?
Emami Ltd's intrinsic value (as of 02 January 2026) is ₹498.72 which is 4.64% lower the current market price of ₹523.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹22,809 Cr. market cap, FY2025-2026 high/low of ₹655/498, reserves of ₹2,887 Cr, and liabilities of ₹3,671 Cr.
What is the Market Cap of Emami Ltd?
The Market Cap of Emami Ltd is 22,809 Cr..
What is the current Stock Price of Emami Ltd as on 02 January 2026?
The current stock price of Emami Ltd as on 02 January 2026 is ₹523.
What is the High / Low of Emami Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Emami Ltd stocks is ₹655/498.
What is the Stock P/E of Emami Ltd?
The Stock P/E of Emami Ltd is 30.3.
What is the Book Value of Emami Ltd?
The Book Value of Emami Ltd is 67.1.
What is the Dividend Yield of Emami Ltd?
The Dividend Yield of Emami Ltd is 1.53 %.
What is the ROCE of Emami Ltd?
The ROCE of Emami Ltd is 32.4 %.
What is the ROE of Emami Ltd?
The ROE of Emami Ltd is 30.2 %.
What is the Face Value of Emami Ltd?
The Face Value of Emami Ltd is 1.00.